Rising crude oil prices lifted the markets to a sharply higher open with the Dow climbing 90 points to 19,260. Nasdaq soared 55 points 5,311.
On the upside
Ocean Power Technologies (Nasdaq: OPTT) entered a joint marketing agreement with Sonalysts.
New Oriental Education & Technology Group (NYSE: EDU) responded to allegations of academic fraud.
Eyegate Pharmaceuticals (Nasdaq: EYEG) reported promising data from the third stage of a Phase 1b/2a trial of iontophoretic EGP-437 to treat ocular inflammation and pain in post-surgical cataract patients.
On the downside
Shares of Gold Fields (NYSE: GFI), Harmony Gold (NYSE: HMY) and Kinross Gold (NYSE: KGC) all fell as gold prices dropped.
Agios Pharmaceuticals (Nasdaq: AGIO) reported new data on AG-348 and AG-519.
Cerecor (Nasdaq: CERC) reported disappointing results from Phase 2 clinical trial of CERC-501.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 index climbed 14 to 2,206. Bitcoin fell $9 to $751.
